Abstract | PURPOSE: METHODS: Observational case report. RESULTS: JFS, a 31-year-old woman, presented with a complaint of blurred vision in her right eye over the preceding 2 months, worsening during the previous month. An examination conducted in May 2013 showed visual acuity of 20/30 in her right eye and 20/20 in her left eye, deteriorating to 20/40 in the right eye 1 month later. Retinography of the right eye revealed a dilated tortuous retinal vessel in the lower temporal arcade, affecting the macular region. Because of progressive deterioration in the patient's visual acuity, she was treated with 3 intravitreal bevacizumab injections, with an interval of 1 month between them. At the end of the proposed treatment, the patient was followed up on an outpatient basis for 12 months, with visual acuity of 20/20 in both eyes and no signs of retinal exudation throughout the entire follow-up period. CONCLUSION: Racemose hemangioma with focal macular involvement may lead to a progressive reduction in visual acuity because of exudation. Further studies need to be conducted to confirm the efficacy of bevacizumab injections to treat vascular malformation; however, this form of management does seem promising.
|
Authors | Alan K Barreira Jr, Aloisio F Nakashima, Vitor K L Takahashi, Geraldo A Marques, Tomás Minelli, Artur M D Santo |
Journal | Retinal cases & brief reports
(Retin Cases Brief Rep)
Vol. 10
Issue 1
Pg. 52-4
( 2016)
ISSN: 1937-1578 [Electronic] United States |
PMID | 26076059
(Publication Type: Case Reports, Journal Article, Observational Study)
|
Chemical References |
- Angiogenesis Inhibitors
- Bevacizumab
|
Topics |
- Adult
- Angiogenesis Inhibitors
(therapeutic use)
- Bevacizumab
(therapeutic use)
- Female
- Hemangioma
(drug therapy)
- Humans
- Macular Edema
(drug therapy)
- Retinal Neoplasms
(drug therapy)
- Treatment Outcome
|